55
Antares Therapeutics, Inc. raises $30M under Reg D
Company raise · Raising · Offering $136.7M · Sold $30M · BOSTON, MA · filed 2025-05-15
Relevant to: Executive & technical recruiting, B2B software & services sales, Commercial banking / treasury, D&O and management-liability insurance, Outsourced accounting / CFO. Lead card pending.
| Andrew Fedder | Executive Officer, Director |
| Adam Friedman | Executive Officer, Director |
| Brian Piper | Executive Officer, Director |
Signed by Andrew Fedder, General Counsel.
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.